Virtually, most MCC patients are in older adults, and immunocompromised, highly antigenic MCV-related MCC tumors could escape from host immune clearance by inducing tolerogenic microenvironment, including a high level of Tregs and upregulation of PD-L1 expression7. This evidence concerns the gene CD274 and Merkel cell skin cancer.